O. Takeuchi and S. Akira, Innate immunity to virus infection, Immunological Reviews, vol.451, issue.1, pp.75-86, 2009.
DOI : 10.1111/j.1600-065X.2008.00737.x

M. Yoneyama and T. Fujita, Recognition of viral nucleic acids in innate immunity, Reviews in Medical Virology, vol.316, issue.1, pp.4-22, 2010.
DOI : 10.1038/ni.1779

C. Wilkins, M. Gale, and J. , Recognition of viruses by cytoplasmic sensors, Current Opinion in Immunology, vol.22, issue.1, pp.41-47, 2010.
DOI : 10.1016/j.coi.2009.12.003

K. Brennan and A. Bowie, Activation of host pattern recognition receptors by viruses, Current Opinion in Microbiology, vol.13, issue.4, pp.503-507, 2010.
DOI : 10.1016/j.mib.2010.05.007

O. Takeuchi and S. Akira, Pattern Recognition Receptors and Inflammation, Cell, vol.140, issue.6, pp.805-820, 2010.
DOI : 10.1016/j.cell.2010.01.022

URL : http://doi.org/10.1016/j.cell.2010.01.022

S. Liu, D. Sanchez, and G. Cheng, New developments in the induction and antiviral effectors of type I interferon, Current Opinion in Immunology, vol.23, issue.1, pp.57-64, 2011.
DOI : 10.1016/j.coi.2010.11.003

S. Akira, S. Uematsu, and O. Takeuchi, Pathogen Recognition and Innate Immunity, Cell, vol.124, issue.4, pp.783-801, 2006.
DOI : 10.1016/j.cell.2006.02.015

H. Kumar, T. Kawai, and S. Akira, Pathogen Recognition by the Innate Immune System, International Reviews of Immunology, vol.185, issue.1, pp.16-34, 2011.
DOI : 10.1038/ni.1859

Y. Loo, M. Gale, and J. , Immune Signaling by RIG-I-like Receptors, Immunity, vol.34, issue.5, pp.680-692, 2011.
DOI : 10.1016/j.immuni.2011.05.003

URL : http://doi.org/10.1016/j.immuni.2011.05.003

S. Belgnaoui, S. Paz, and J. Hiscott, Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter, Current Opinion in Immunology, vol.23, issue.5, pp.564-572, 2011.
DOI : 10.1016/j.coi.2011.08.001

B. Beutler, TLRs and innate immunity, Blood, vol.113, issue.7, pp.1399-1407, 2009.
DOI : 10.1182/blood-2008-07-019307

T. Kawai and S. Akira, Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity, Immunity, vol.34, issue.5, pp.637-650, 2011.
DOI : 10.1016/j.immuni.2011.05.006

F. Jiang, A. Ramanathan, M. Miller, G. Tang, M. Gale et al., Structural basis of RNA recognition and activation by innate immune receptor RIG-I, Nature, vol.2, issue.7373, pp.423-427, 2011.
DOI : 10.1038/nature10537

M. Yoneyama and T. Fujita, Function of RIG-I-like Receptors in Antiviral Innate Immunity, Journal of Biological Chemistry, vol.282, issue.21, pp.15315-15318, 2007.
DOI : 10.1074/jbc.R700007200

T. Kawai, K. Takahashi, S. Sato, C. Coban, and H. Kumar, IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction, Nature Immunology, vol.174, issue.10, pp.981-988, 2005.
DOI : 10.1093/emboj/cdf505

E. Meylan, J. Curran, K. Hofmann, D. Moradpour, and M. Binder, Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus, Nature, vol.69, issue.7062, pp.1167-1172, 2005.
DOI : 10.1016/j.cell.2005.08.012

M. Schlee, A. Roth, V. Hornung, C. Hagmann, and V. Wimmenauer, Recognition of 5??? Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus, Immunity, vol.31, issue.1, pp.25-34, 2009.
DOI : 10.1016/j.immuni.2009.05.008

E. Kowalinski, T. Lunardi, A. Mccarthy, J. Louber, and J. Brunel, Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA, Cell, vol.147, issue.2, pp.423-435, 2011.
DOI : 10.1016/j.cell.2011.09.039

S. Myong, S. Cui, P. Cornish, A. Kirchhofer, and M. Gack, Cytosolic Viral Sensor RIG-I Is a 5'-Triphosphate-Dependent Translocase on Double-Stranded RNA, Science, vol.323, issue.5917, pp.1070-1074, 2009.
DOI : 10.1126/science.1168352

X. Jiang, L. Kinch, C. Brautigam, X. Chen, and F. Du, Ubiquitin-Induced Oligomerization of the RNA Sensors RIG-I and MDA5 Activates Antiviral Innate Immune Response, Immunity, vol.36, issue.6, pp.959-973, 2012.
DOI : 10.1016/j.immuni.2012.03.022

S. Sharma, B. Tenoever, N. Grandvaux, G. Zhou, and R. Lin, Triggering the Interferon Antiviral Response Through an IKK-Related Pathway, Science, vol.300, issue.5622, pp.1148-1151, 2003.
DOI : 10.1126/science.1081315

L. Xu, Y. Wang, K. Han, L. Li, and Z. Zhai, VISA Is an Adapter Protein Required for Virus-Triggered IFN-?? Signaling, Molecular Cell, vol.19, issue.6, pp.727-740, 2005.
DOI : 10.1016/j.molcel.2005.08.014

R. Seth, L. Sun, and E. Ckac, Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-??B and IRF3, Cell, vol.122, issue.5, pp.669-682, 2005.
DOI : 10.1016/j.cell.2005.08.012

N. Tamassia, L. Moigne, V. Rossato, M. Donini, M. Mccartney et al., Activation of an Immunoregulatory and Antiviral Gene Expression Program in Poly(I:C)-Transfected Human Neutrophils, The Journal of Immunology, vol.181, issue.9, pp.6563-6573, 2008.
DOI : 10.4049/jimmunol.181.9.6563

T. Kawai and S. Akira, Toll-like Receptor and RIG-1-like Receptor Signaling, Annals of the New York Academy of Sciences, vol.101, issue.1, pp.1-20, 2008.
DOI : 10.1196/annals.1443.020

B. Wang and E. Fish, The yin and yang of viruses and interferons, Trends in Immunology, vol.33, issue.4, pp.190-197, 2012.
DOI : 10.1016/j.it.2012.01.004

P. Nakhaei, S. Paz, and J. Hiscott, Activation of Interferon Gene Expression Through Toll-like Receptor-dependent and -independent Pathways, 2006.
DOI : 10.1002/3527608206.ch2

A. Sadler and B. Williams, Interferon-inducible antiviral effectors, Nature Reviews Immunology, vol.97, issue.7, pp.559-568, 2008.
DOI : 10.1038/nri2314

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522268

J. Schoggins, S. Wilson, M. Panis, M. Murphy, and C. Jones, A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, vol.81, issue.7344, pp.481-485, 2011.
DOI : 10.1038/nature09907

V. Hornung, J. Ellegast, S. Kim, K. Brzozka, and A. Jung, 5'-Triphosphate RNA Is the Ligand for RIG-I, Science, vol.314, issue.5801, pp.994-997, 2006.
DOI : 10.1126/science.1132505

A. Pichlmair, O. Schulz, C. Tan, T. Naslund, and P. Liljestrom, RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates, Science, vol.314, issue.5801, pp.997-1001, 2006.
DOI : 10.1126/science.1132998

D. Kim, M. Longo, Y. Han, P. Lundberg, and E. Cantin, Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase, Nature Biotechnology, vol.22, issue.3, pp.321-325, 2004.
DOI : 10.1038/nbt940

T. Fujita, A Nonself RNA Pattern: Tri-p to Panhandle, Immunity, vol.31, issue.1, pp.4-5, 2009.
DOI : 10.1016/j.immuni.2009.06.014

M. Schlee and G. Hartmann, The Chase for the RIG-I Ligand???Recent Advances, Molecular Therapy, vol.18, issue.7, pp.1254-1262, 2010.
DOI : 10.1038/mt.2010.90

H. Kato, O. Takeuchi, E. Mikamo-satoh, R. Hirai, and T. Kawai, Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid???inducible gene-I and melanoma differentiation???associated gene 5, The Journal of Experimental Medicine, vol.89, issue.7, pp.1601-1610, 2008.
DOI : 10.1016/j.jsb.2005.05.002

A. Baum, R. Sachidanandam, and A. Garcia-sastre, Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing, Proceedings of the National Academy of Sciences, vol.107, issue.37, pp.16303-16308, 2010.
DOI : 10.1073/pnas.1005077107

J. Rehwinkel and C. Sousa, RIGorous Detection: Exposing Virus Through RNA Sensing, Science, vol.327, issue.5963, pp.284-286, 2010.
DOI : 10.1126/science.1185068

J. Rehwinkel, C. Tan, D. Goubau, O. Schulz, and A. Pichlmair, RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection, Cell, vol.140, issue.3, pp.397-408, 2010.
DOI : 10.1016/j.cell.2010.01.020

URL : http://doi.org/10.1016/j.cell.2010.01.020

S. Cui, E. Katharina, A. Kirchhofer, K. Brzózka, and A. Lammens, The C-Terminal Regulatory Domain Is the RNA 5???-Triphosphate Sensor of RIG-I, Molecular Cell, vol.29, issue.2, pp.169-179, 2008.
DOI : 10.1016/j.molcel.2007.10.032

D. Goubau, R. Romieu-mourez, M. Solis, E. Hernandez, and T. Mesplede, Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7, European Journal of Immunology, vol.37, issue.2, pp.527-540, 2009.
DOI : 10.1002/eji.200838832

M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, and T. Imaizumi, The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses, Nature Immunology, vol.120, issue.7, pp.730-737, 2004.
DOI : 10.1038/ni910

R. Akhurst and A. Hata, Targeting the TGF?? signalling pathway in disease, Nature Reviews Drug Discovery, vol.298, issue.10, pp.790-811, 2012.
DOI : 10.1038/nrd3810

F. Mcnab, R. Rajsbaum, J. Stoye, O. Garra, and A. , Tripartite-motif proteins and innate immune regulation, Current Opinion in Immunology, vol.23, issue.1, pp.46-56, 2011.
DOI : 10.1016/j.coi.2010.10.021

K. Ozato, D. Shin, T. Chang, and H. Morse, TRIM family proteins and their emerging roles in innate immunity, Nature Reviews Immunology, vol.361, issue.11, pp.849-860, 2008.
DOI : 10.1038/nri2413

S. Barr, J. Smiley, and F. Bushman, The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22, PLoS Pathogens, vol.272, issue.2, p.1000007, 2008.
DOI : 10.1371/journal.ppat.1000007.s001

A. Brass, I. Huang, Y. Benita, S. John, and M. Krishnan, The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus, Cell, vol.139, issue.7, pp.1243-1254, 2009.
DOI : 10.1016/j.cell.2009.12.017

E. Feeley, J. Sims, S. John, C. Chin, and T. Pertel, IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry, PLoS Pathogens, vol.3, issue.10, p.1002337, 2011.
DOI : 10.1371/journal.ppat.1002337.s010

A. Everitt, C. S. Pertel, T. John, S. Wash, and R. , IFITM3 restricts the morbidity and mortality associated with influenza, Nature, vol.335, issue.7395, pp.519-523, 2012.
DOI : 10.1038/nature10921

O. Haller, P. Staeheli, and G. Kochs, Interferon-induced Mx proteins in antiviral host defense, Biochimie, vol.89, issue.6-7, pp.812-818, 2007.
DOI : 10.1016/j.biochi.2007.04.015

O. Haller, S. Stertz, and G. Kochs, The Mx GTPase family of interferon-induced antiviral proteins, Microbes and Infection, vol.9, issue.14-15, pp.1636-1643, 2007.
DOI : 10.1016/j.micinf.2007.09.010

D. Jiang, H. Guo, C. Xu, J. Chang, and B. Gu, Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus, Journal of Virology, vol.82, issue.4, pp.1665-1678, 2008.
DOI : 10.1128/JVI.02113-07

K. Helbig, D. Lau, L. Semendric, H. Harley, and M. Beard, Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector, Hepatology, vol.101, issue.3, pp.702-710, 2005.
DOI : 10.1002/hep.20844

X. Wang, E. Hinson, and P. Cresswell, The Interferon-Inducible Protein Viperin Inhibits Influenza Virus Release by Perturbing Lipid Rafts, Cell Host & Microbe, vol.2, issue.2, pp.96-105, 2007.
DOI : 10.1016/j.chom.2007.06.009

S. Maher, F. Sheikh, A. Scarzello, A. Romero-weaver, and D. Baker, IFN-?? and IFN-?? differ in their antiproliferative effects and duration of JAK/STAT signaling activity, Cancer Biology & Therapy, vol.7, issue.7, pp.1109-1115, 2008.
DOI : 10.4161/cbt.7.7.6192

M. Mordstein, G. Kochs, L. Dumoutier, J. Renauld, and S. Paludan, Interferon-?? Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses, PLoS Pathogens, vol.463, issue.3, p.1000151, 2008.
DOI : 10.1371/journal.ppat.1000151.g006

R. Tian, H. Guo, J. Wei, C. Yang, and S. He, IFN-?? inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production, Antiviral Research, vol.95, issue.1, pp.57-65, 2012.
DOI : 10.1016/j.antiviral.2012.04.011

N. Pagliaccetti, R. Eduardo, S. Kleinstein, X. Mu, and P. Bandi, Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication, Journal of Biological Chemistry, vol.283, issue.44, pp.30079-30089, 2008.
DOI : 10.1074/jbc.M804296200

C. Kelly, P. Klenerman, and E. Barnes, Interferon lambdas: the next cytokine storm, Gut, vol.60, issue.9, pp.1284-1293, 2011.
DOI : 10.1136/gut.2010.222976

A. Yoshimura and H. Yasukawa, JAK's SOCS: A Mechanism of Inhibition, Immunity, vol.36, issue.2, pp.157-159, 2012.
DOI : 10.1016/j.immuni.2012.01.010

N. Shembade, A. Ma, and E. Harhaj, Inhibition of NF-??B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes, Science, vol.327, issue.5969, pp.1135-1139, 2010.
DOI : 10.1126/science.1182364

P. Tak and G. Firestein, NF-??B: a key role in inflammatory diseases, Journal of Clinical Investigation, vol.107, issue.1, pp.7-11, 2001.
DOI : 10.1172/JCI11830

A. Dejean, D. Beisner, I. Ch-'en, Y. Kerdiles, and A. Babour, Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells, Nature Immunology, vol.116, issue.5, pp.504-513, 2009.
DOI : 10.1038/87730

D. Kobasa, S. Jones, K. Shinya, J. Kash, and J. Copps, Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus, Nature, vol.33, issue.7125, pp.319-323, 2007.
DOI : 10.1038/nature05495

P. Ranjan, L. Jayashankar, V. Deyde, H. Zeng, and W. Davis, 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication, Virology Journal, vol.7, issue.1, p.102, 2010.
DOI : 10.1186/1743-422X-7-102

URL : http://doi.org/10.1186/1743-422x-7-102

K. Chakravarthy, A. Bonoiu, W. Davis, P. Ranjan, and H. Ding, Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication, Proceedings of the National Academy of Sciences, vol.107, issue.22, pp.10172-10177, 2010.
DOI : 10.1073/pnas.0914561107

L. Lin, Q. Liu, N. Berube, S. Detmer, and Y. Zhou, 5'-Triphosphate-Short Interfering RNA: Potent Inhibition of Influenza A Virus Infection by Gene Silencing and RIG-I Activation, Journal of Virology, vol.86, issue.19, pp.10359-69, 2012.
DOI : 10.1128/JVI.00665-12

L. Martinez-gil, P. Goff, R. Hai, A. Garcia-sastre, and M. Shaw, A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant, Journal of Virology, vol.87, issue.3, pp.1290-1300, 2013.
DOI : 10.1128/JVI.02338-12

A. Takaoka, S. Hayakawa, H. Yanai, D. Stoiber, and H. Negishi, Integration of interferon-??/?? signalling to p53 responses in tumour suppression and antiviral defence, Nature, vol.424, issue.6948, pp.516-523, 2003.
DOI : 10.1038/nature01850

H. Kelchtermans, A. Billiau, and P. Matthys, How interferon-?? keeps autoimmune diseases in check, Trends in Immunology, vol.29, issue.10, pp.479-486, 2008.
DOI : 10.1016/j.it.2008.07.002

F. Lotrich, R. Ferrell, M. Rabinovitz, and B. Pollock, Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism, Biological Psychiatry, vol.65, issue.4, pp.344-348, 2009.
DOI : 10.1016/j.biopsych.2008.08.009

M. Caskey, F. Lefebvre, A. Filali-mouhim, M. Cameron, and J. Goulet, Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans, The Journal of Experimental Medicine, vol.57, issue.12, pp.2357-2366, 2011.
DOI : 10.4049/jimmunol.181.1.276

L. Mazaleuskaya, R. Veltrop, N. Ikpeze, J. Martin-garcia, and S. Navas-martin, Protective Role of Toll-like Receptor 3-Induced Type I Interferon in Murine Coronavirus Infection of Macrophages, Viruses, vol.4, issue.12, pp.901-923, 2012.
DOI : 10.3390/v4050901

J. Zhao, C. Wohlford-lenane, J. Zhao, E. Fleming, and T. Lane, Intranasal Treatment with Poly(I{middle dot}C) Protects Aged Mice from Lethal Respiratory Virus Infections, Journal of Virology, vol.86, issue.21, pp.11416-11440, 2012.
DOI : 10.1128/JVI.01410-12

D. Gaucher, R. Therrien, N. Kettaf, B. Angermann, and G. Boucher, Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses, The Journal of Experimental Medicine, vol.13, issue.13, pp.3119-3131, 2008.
DOI : 10.1084/jem.20031598

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605227

H. Kato, S. Sato, M. Yoneyama, M. Yamamoto, and S. Uematsu, Cell Type-Specific Involvement of RIG-I in Antiviral Response, Immunity, vol.23, issue.1, pp.19-28, 2005.
DOI : 10.1016/j.immuni.2005.04.010

L. Gitlin, W. Barchet, S. Gilfillan, M. Cella, and B. Beutler, Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus, Proceedings of the National Academy of Sciences, vol.103, issue.22, pp.8459-8464, 2006.
DOI : 10.1073/pnas.0603082103

S. Mccartney, W. Vermi, S. Gilfillan, M. Cella, and T. Murphy, Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells, The Journal of Experimental Medicine, vol.161, issue.13, pp.2967-2976, 2009.
DOI : 10.1146/annurev.immunol.17.1.19

T. Zhao, L. Yang, Q. Sun, M. Arguello, and D. Ballard, The NEMO adaptor bridges the nuclear factor-??B and interferon regulatory factor signaling pathways, Nature Immunology, vol.78, issue.6, pp.592-600, 2007.
DOI : 10.1038/ni1465

D. Stojdl, B. Lichty, B. Tenoever, J. Paterson, and A. Power, VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents, Cancer Cell, vol.4, issue.4, pp.263-275, 2003.
DOI : 10.1016/S1535-6108(03)00241-1

V. Tumilasci, S. Oliere, T. Nguyen, A. Shamy, and J. Bell, Targeting the Apoptotic Pathway with BCL-2 Inhibitors Sensitizes Primary Chronic Lymphocytic Leukemia Cells to Vesicular Stomatitis Virus-Induced Oncolysis, Journal of Virology, vol.82, issue.17, pp.8487-8499, 2008.
DOI : 10.1128/JVI.00851-08

C. Myskiw, J. Arsenio, C. Hammett, R. Van-bruggen, and Y. Deschambault, Comparative Analysis of Poxvirus Orthologues of the Vaccinia Virus E3 Protein: Modulation of Protein Kinase R Activity, Cytokine Responses, and Virus Pathogenicity, Journal of Virology, vol.85, issue.23, pp.12280-12291, 2011.
DOI : 10.1128/JVI.05505-11

J. Arseniob, Y. Deschambaulta, and J. Cao, Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells, Virology, vol.377, issue.1, pp.124-132, 2008.
DOI : 10.1016/j.virol.2008.04.014

M. Schindler, J. Munch, and F. Kirchhoff, Human Immunodeficiency Virus Type 1 Inhibits DNA Damage-Triggered Apoptosis by a Nef-Independent Mechanism, Journal of Virology, vol.79, issue.9, pp.5489-5498, 2005.
DOI : 10.1128/JVI.79.9.5489-5498.2005

M. Schindler, S. Wurfl, P. Benaroch, T. Greenough, and R. Daniels, Down-Modulation of Mature Major Histocompatibility Complex Class II and Up-Regulation of Invariant Chain Cell Surface Expression Are Well-Conserved Functions of Human and Simian Immunodeficiency Virus nef Alleles, Journal of Virology, vol.77, issue.19, pp.10548-10556, 2003.
DOI : 10.1128/JVI.77.19.10548-10556.2003

K. Szretter, A. Balish, and J. Katz, Influenza: Propagation, Quantification, and Storage, Curr Protoc Microbiol Chapter, vol.56, 2006.
DOI : 10.1002/0471729256.mc15g01s3

G. Smyth, R. Gentleman, V. Carey, S. Dudoit, and R. Irizarry, limma: Linear Models for Microarray Data, Bioinformatics and Computational Biology Solutions using R and Bioconductor, pp.397-420, 2005.
DOI : 10.1007/0-387-29362-0_23

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.182.2271

B. Yah and Y. , Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc Series B Stat Methodol, vol.57, pp.289-300, 1995.